28 29 Financial review profits up margin improved Analysis of results In the commentary on performance below, comparatives have been restated to exclude the effects of foreign currency translation to aid understanding.
Current year numbers reflect the impact of the results of our Chinese joint venture post acquisition in January 2007 of 2.5 million of Durex sales and 1.4 million of operating profit.
Sales Sales of our total business were 480.2 million, 8.4 per cent ahead of last year after excluding adverse foreign currency movements of 7.5 million.
Sales of our branded consumer business comprising Durex, Scholl footcare, Scholl footwear and locally owned brands were 426.2 million, representing Mark Moran growth of 8.8 per cent against last year.
Sales are analysed Finance Director in Table 1 on page 31.
Durex SSLs results for the year ended 31 March 2007 are set Durex sales were 187.1 million, 17.5 per cent ahead of last out on page 48.
Total sales were 480.2 million compared year on a currency adjusted basis and 16.0 per cent ahead with 443.1 million last year generating operating profit excluding the impact of the China acquisition, with continued before financing and after associates of 56.1 million growth particularly in Iberia and Eastern Europe.
The operating margin was up one percentage point to 11.7 per cent 2006: 10.7 per cent.
Durex continues to be developed as a brand, which not only provides safe sex but focuses on sexual wellbeing.
Our Pre-tax profit of 46.9 million compares to 35.7 million last product range is growing in all three core areas of condoms, year.
Basic earnings per share increased by 33.6 per cent to personal lubricants and devices enabling people to enjoy 17.1 pence from 12.8 pence.
Operating cash flow before restructuring was 60.9 million Sales of the Durex Play range more than doubled from compared to 40.6 million last year.
Net debt at the year 12 million last year to 27 million as the result of the end was 88.7 million 2006: 91.5 million after the continued expansion of our range of personal lubricants acquisition of our former Chinese joint venture in January and the wide distribution and consumer acceptance of Play for 19.2 million.
As part of this transaction cash of Vibrations, the innovative vibrating ring launched last year.
Sales of Durex condoms have increased by 8.8 per cent to 160.1 million as the premium range of condoms, such as Operating expenses as a percentage of sales Basic earnings per share 06 07 27.0% 06 07 17.1 pence 05 06 28.3% 05 06 12.8 pence 04 05 30.2% 04 05 9.5 pence At constant exchange rates 2004 05 relates to normal business operations Pleasuremax with its warming variant and Performa, continue in the first half.
However, this decline was offset by a strong to perform well with innovative advertising and promotion performance from Mister Baby a range of mother and baby supporting extended distribution.
Scholl footcare Other sales Sales of Scholl footcare grew over 6 per cent to 100 million Sales of our other products were 54.0 million, 4.9 per cent on an underlying basis.
The growth has largely been driven by above last year, on an underlying basis, as a result of higher the successful introduction of new, innovative, technically sales of our low margin unbranded condom business.
Other advanced products such as Cracked Heel Repair Cream sales also include contract manufacturing and sales from and Freeze Verruca & Wart Remover particularly in UK and distribution of third party products.
France and Party Feet line extensions throughout the rest of Europe and Asia Pacific.
Gross margin The gross margin for the Group is 59.2 per cent, which In addition our decision to switch 6 million of marketing is 1 per cent down on last year after adjusting for foreign expenditure from the second to the first half of the year to currency movements.
This is mainly due to the growth in support the new product launches during the key spring and the Durex Play range and the third party sourcing of our summer periods throughout Europe has also helped drive new footcare products.
Market development expenditure Scholl footwear The Group spent 70.7 million on market development Underlying sales of Scholl footwear grew by 1.8 per cent to in the year ended 31 March 2007.
This reflects an increase 66.8 million as the turnaround of the European business of 2.7 million on the previous year currency adjusted continues.
European sales grew by 5.7 per cent to 56.0 million, as we continue to commit to investing in advertising our whilst the Japanese and Thai businesses, where the business consumer brands.
model differs from Europe, saw a decline.
Brand contribution The brand ideal of foot science made relevant is now well Brand contribution is one of the Groups key measures established within Europe and underpins our strategy of for success.
It is defined as sales less cost of sales, market providing well-designed, stylish shoes that take care of feet.
development expenditure and variable selling costs.
Brand In addition we expect to achieve further growth in extended contribution was 184.0 million, representing an increase distribution beyond our traditional channel of pharmacy into of over 13 million compared to last year currency adjusted high street footwear retailers.
and represents over 38 per cent of sales.
Locally owned brands Selling, general & administration costs SG&A Sales from our portfolio of locally owned brands were SG&A costs were 129.7 million, higher in absolute terms 72.3 million, marginally lower than last year as a result of than last year but continuing to reduce as a percentage of the competitive retail environment in the UK as we reported sales by more than 1 per cent to 27 per cent on a currency 30 31 Our commitment to challenging Financial review the cost base remains one of the fundamental elements in achieving our operating profit growth targets adjusted basis.
Our commitment to challenging the cost base remains one of the fundamental elements in achieving our operating profit growth targets.
Operating profit Operating profit including income from associates was 56.1 million up 18.9 per cent compared to last year 2006: 47.2 million currency adjusted driven by organic sales growth combined with tight cost control.
Currency adjusted operating margin was up by 1 per cent to 11.7 per cent.
The American business suffered a statutory operating loss of 1.9 million compared to an operating profit of 1.3 million in 2006 largely as a result of an unsuccessful local product launch.
Financing costs and taxation Total net interest cost for the year was 9.2 million 2006: 13.4 million.
The net interest charge from financing has remained fairly constant at 8.0 million 2006: 7.9 million despite the acquisition of the remaining 50 per cent of our former Chinese joint venture in January for 19.2 million with cash acquired of 5.6 million.
The net interest charge relating to IAS 19 Employee Benefits has reduced to 3.0 million mainly as a result of improved returns from assets 2006: 3.4 million.
The impact of IAS 39 Financial 12% Instruments has this year resulted in a non-cash credit of 1.8 million compared with a charge of 2.1 million in 2006, operating margin up reflecting the movement of the US$ bond yield during the year.
one percentage point The tax charge of 13.1 million represents a tax rate of 29 per cent of operating profit pre-associate income 2006: 28.9 per cent.
49.4m Earnings and financial condition strong operating Profit after tax and minority interests was 32.5 million cash flow 2006: 24.2 million which generated basic earnings per 1 Table 1 As reported Adjusted Adjusted 31 Mar 2007 31 Mar 2006 growth m m % 2 Durex 187.1 159.2 17.5 Scholl footcare 100.0 94.2 6.2 Scholl footwear 66.8 65.6 1.8 Locally owned brands 72.3 72.6 0.4 Total branded customer 426.2 391.6 8.8 Other 54.0 51.5 4.9 Total consumer 480.2 443.1 8.4 1 Adjusted for currency movements.
2 Includes Durex sales of 2.5 million in China following acquisition in January 2007. share of 17.1 pence 2006: 12.8 pence.
Shareholders funds exposures using forward contracts and options, usually at 31 March 2007 were 97.6 million 2006: 67.0 million.
Cash flow and investing activities Interest rate exposure objective Operating cash flow was 60.9 million compared to The interest rate risk management policy aims to reduce 40.6 million last year.
This is defined as cash generated the impact of interest rate fluctuations on the Groups from operations of 49.4 million 2006: 32.0 million net interest expense to acceptable levels.
This is achieved before cash paid in respect of restructuring provisions through balancing the ratio of fixed or hedged debt to of 11.5 million 2006: 8.6 million.
those financial liabilities with floating interest rates.
Board approved instruments available to hedge this exposure Litigation include interest rate swaps, interest rate options and This is detailed in note 25. forward rate agreements.
Details of the interest rate analysis are given in note 22.
Capital structure and treasury policy International Accounting Standards 32 and 39 Liquidity risk IAS 32 and 39 require that certain disclosures relating to The primary objective of the Group Treasury Policy is to financial instruments are given in the financial statements, ensure that the Group is able at all times to meet its financial in order to provide information on the impact of such commitments as they fall due.
To facilitate this, the Group instruments on the Groups risk profile, how this may affect Treasury department is responsible for the management the Groups performance and financial position, and how of cash and liquid resources for the whole Group, and those risks are managed.
The impact of those financial ensures that the Group has sufficient liquidity to meet any instruments is considered in note 22. reasonable change in funding requirements.
The Groups liquidity as defined as the aggregate of the Groups cash, Foreign exchange risk objective liquid resources and central undrawn committed facilities The nature of the Groups trading activities generates as at 31 March 2007, amounted to 256.4 million 2006: transactional foreign exchange rate risks.
the sourcing of raw materials from different countries, the location of Group production facilities throughout the Mark Moran world and the sale and distribution of finished goods in many Group Finance Director locations.
The objective of the Groups foreign exchange 21 May 2007 policy is to minimise the trade exposure to foreign exchange rate fluctuations for the overseas entities and manage the risk from the centre.
This requires that all trading-related exposures should be centralised in accordance with prescribed procedures and timetables under the direction of the Group Treasury Function, which hedges the major
